1. TXLNG improves insulin resistance in obese subjects in vitro and in vivo by inhibiting ATF4 transcriptional activity. (1st June 2023) Authors: Tao, Jing; Gu, Peipei; Lai, Hongmei; Peng, Hui; Guo, Zitong; Yuan, Yujuan; Yu, Xiaolin; Shen, Xin; Liu, Jun; Xier, Zulipiyemu; Li, Guoqing; Yang, Yining Journal: Molecular and cellular endocrinology Issue: Volume 568/569(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗